These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37307940)

  • 1. von Hippel-Lindau-targeting microRNA-143-3p attenuates mitochondrial abnormality via AMPK/PGC-1α axis in Parkinson's disease.
    Liang Y; Gu M; Liang X; Zhou Y; Yang Q; Wang Z; Yao W; Gao X; Chen S
    Exp Cell Res; 2023 Aug; 429(2):113684. PubMed ID: 37307940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-193b-3p/ PGC-1α pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Mesarosova L; Scheper M; Iyer A; Anink JJ; Mills JD; Aronica E
    Neurobiol Dis; 2024 Sep; 199():106587. PubMed ID: 38950713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the regulatory of miR-101-3p on ZNF746 in a Parkinson's disease cell model: Implications for therapeutic targeting.
    Mahmoudian Esfahani M; Mostashfi M; Vaheb Hosseinabadi S; Hashemi MS; Peymani M; Zohrabi D; Angaji SA; Nasr-Esfahani MH; Ghaedi K
    Neurosci Res; 2024 Jun; 203():18-27. PubMed ID: 38103579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models.
    Guo B; Zheng C; Cao J; Luo F; Li H; Hu S; Mingyuan Lee S; Yang X; Zhang G; Zhang Z; Sun Y; Wang Y
    J Adv Res; 2024 Oct; 64():195-211. PubMed ID: 37989471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction.
    Li K; Zhang J; Ji C; Wang L
    Mol Cells; 2016 Jul; 39(7):543-9. PubMed ID: 27329039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microRNA-130b in placental PGC-1α/TFAM mitochondrial biogenesis pathway.
    Jiang S; Teague AM; Tryggestad JB; Chernausek SD
    Biochem Biophys Res Commun; 2017 Jun; 487(3):607-612. PubMed ID: 28433632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoidan Suppresses Mitochondrial Dysfunction and Cell Death against 1-Methyl-4-Phenylpyridinum-Induced Neuronal Cytotoxicity via Regulation of PGC-1α Expression.
    Han YS; Lee JH; Lee SH
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson's disease model in rats: Role of AMPK/SIRT-1/PGC-1α signaling and autophagy.
    Elesawy WH; El-Sahar AE; Sayed RH; Ashour AM; Alsufyani SE; Arab HH; Kandil EA
    Int Immunopharmacol; 2024 Sep; 138():112640. PubMed ID: 38981225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
    J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
    Ferretta A; Gaballo A; Tanzarella P; Piccoli C; Capitanio N; Nico B; Annese T; Di Paola M; Dell'aquila C; De Mari M; Ferranini E; Bonifati V; Pacelli C; Cocco T
    Biochim Biophys Acta; 2014 Jul; 1842(7):902-15. PubMed ID: 24582596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson's disease.
    Fan F; Li S; Wen Z; Ye Q; Chen X; Ye Q
    Aging (Albany NY); 2020 May; 12(10):9461-9474. PubMed ID: 32452827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
    Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-29b-3p degenerates terminally differentiated dopaminergic SH-SY5Y cells by perturbation of mitochondrial functions.
    Sarkar S; Pandey A; Yadav SK; Raghuwanshi P; Siddiqui MH; Srikrishna S; Pant AB; Yadav S
    J Neurochem; 2024 Jul; 168(7):1297-1316. PubMed ID: 38413218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis.
    Xue Y; Wei Z; Ding H; Wang Q; Zhou Z; Zheng S; Zhang Y; Hou D; Liu Y; Zen K; Zhang CY; Li J; Wang D; Jiang X
    Atherosclerosis; 2015 Aug; 241(2):671-81. PubMed ID: 26117405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid.
    Lin CY; Huang YN; Fu RH; Liao YH; Kuo TY; Tsai CW
    Phytomedicine; 2021 Jan; 80():153369. PubMed ID: 33070082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBDE-47 induces impairment of mitochondrial biogenesis and subsequent neurotoxicity through miR-128-3p/PGC-1α axis.
    Tian Z; Li J; Song L; Xie L; Li D; Xia T; Wang A
    Toxicol Sci; 2023 Jan; 191(1):123-134. PubMed ID: 36269211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 Protects Dopaminergic Neurons in Parkinson's Disease Models via PGC-1α-Mediated Mitochondrial Biogenesis.
    Chen Y; Jiang Y; Yang Y; Huang X; Sun C
    Neurotox Res; 2021 Oct; 39(5):1393-1404. PubMed ID: 34251648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.